We represented AccuReg Software, a healthcare technology solutions company, in its acquisition of Zenig, LLC, a digital patient technology company. This transformative transaction builds upon AccuReg’s strategy to seamlessly integrate digital patient engagement with the revenue cycle to and continues to build upon its marketing leading patient access suite.
AccuReg Software Acquires Zenig
You Also May Be Interested In:
-
-
Representation of Parthenon Capital, a growth-oriented private equity firm, as healthcare regulatory counsel in its investment in RxSense, a high-growth healthcare technology company that utilizes its proprietary technology platform to provide innovative prescription savings solutions to consumers and pharmacy benefits administration and analytics to enterprise customers
-
Lead Counsel to POINT Biopharma Inc. in connection with its proposed SPAC business combination with Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. I (Nasdaq: RACA), a special purpose acquisition company, sponsored by RA Capital Management. Upon closing, the combined company will be named POINT Biopharma Global Inc. and is expected to be listed on Nasdaq under the ticker symbol “PNT”.